Epitope-based precision immunotherapy of Type 1 diabetes

Antigen-specific immunotherapies (ASITs) address important clinical needs in treating autoimmune diseases. However, Type 1 diabetes is a heterogeneous disease wherein patient characteristics influence responsiveness to ASITs. Targeting not only disease-relevant T cell populations, but also specific...

Descripción completa

Detalles Bibliográficos
Autores principales: Firdessa Fite, Rebuma, Bechi Genzano, Camillo, Mallone, Roberto, Creusot, Remi J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Immunotherapy - Other
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980607/
https://www.ncbi.nlm.nih.gov/pubmed/36656048
http://dx.doi.org/10.1080/21645515.2022.2154098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980607/
https://www.ncbi.nlm.nih.gov/pubmed/36656048
http://dx.doi.org/10.1080/21645515.2022.2154098

Ejemplares similares